Global Next Generation Cancer Diagnostics Market By Product Type (Liquid Biopsy, Genetic Testing, Next Generation Sequencing, Immunoassays, and Radiomics), By Application (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, and Leukemia), By End-user (Hospitals, Research Institutions, Laboratories, and Diagnostic Centers), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Table of Contents

• 1. Executive Summary
  • 1.1. Definition
  • 1.2. Market Snapshot
  • 1.3. Market Overview
  • 1.4. Segment Overview
  • 1.5. Regional Overview
  • 1.6. Competitive Landscape
  • 1.7. Taxonomy
• 2. Global Market Overview
  • 2.1. Global Market Insights and Industry Overview
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunities
    • 2.2.4. Key Next Generation Cancer Diagnostics Market Trends
  • 2.3. Regulatory Framework
  • 2.4. Opportunity Map Analysis
  • 2.5. Opportunity Orbits
  • 2.6. PESTLE Analysis
  • 2.7. PORTER’S Five Force Analysis
  • 2.8. Drivers & Restraints Impact Analysis
  • 2.9. Value Chain Analysis
    • 2.9.1. List of Raw Materials Suppliers
    • 2.9.2. List of Next Generation Cancer Diagnostics Manufacturers
    • 2.9.3. List of Dealer/Distributors
  • 2.10. Regional Market Share and BPS Analysis
  • 2.11. Impact of Macro-economic Factors/Geopolitical Factors
• 3. Global Next Generation Cancer Diagnostics Market Analysis and Forecast, By Segment, 2020-2034
  • 3.1. Key Findings
  • 3.2. Global Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 3.3. Global Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Product Type
    • 3.3.1. Next Generation Sequencing
    • 3.3.1.1. Insights
    • 3.3.1.2. Key Takeaways
    • 3.3.2. Liquid Biopsy
      • 3.3.2.1. Insights
      • 3.3.2.2. Key Takeaways
    • 3.3.3. Genetic Testing
      • 3.3.3.1. Insights
      • 3.3.3.2. Key Takeaways
    • 3.3.4. Immunoassays
      • 3.3.4.1. Insights
      • 3.3.4.2. Key Takeaways
    • 3.3.5. Radiomics
      • 3.3.5.1. Insights
      • 3.3.5.2. Key Takeaways
  • 3.4. Global Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 3.5. Global Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Application
    • 3.5.1. Breast Cancer
      • 3.5.1.1. Insights
      • 3.5.1.2. Key Takeaways
    • 3.5.2. Colorectal Cancer
      • 3.5.2.1. Insights
      • 3.5.2.2. Key Takeaways
    • 3.5.3. Lung Cancer
      • 3.5.3.1. Insights
      • 3.5.3.2. Key Takeaways
    • 3.5.4. Prostate Cancer
      • 3.5.4.1. Insights
      • 3.5.4.2. Key Takeaways
    • 3.5.5. Leukemia
      • 3.5.5.1. Insights
      • 3.5.5.2. Key Takeaways
  • 3.6. Global Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  • 3.7. Global Next Generation Cancer Diagnostics Market Attractiveness Analysis, By End-user
    • 3.7.1. Hospitals
      • 3.7.1.1. Insights
      • 3.7.1.2. Key Takeaways
    • 3.7.2. Research Institutions
      • 3.7.2.1. Insights
      • 3.7.2.2. Key Takeaways
    • 3.7.3. Laboratories
      • 3.7.3.1. Insights
      • 3.7.3.2. Key Takeaways
    • 3.7.4. Diagnostic Centers
      • 3.7.4.1. Insights
      • 3.7.4.2. Key Takeaways
  • 4. Global Next Generation Cancer Diagnostics Market Analysis and Forecast, By Region, 2020-2034
  • 4.1. Key Findings
  • 4.2. Global Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
    • 4.2.1. North America
      • 4.2.1.1. Regional Insights
    • 4.2.2. Europe
      • 4.2.2.1. Regional Insights
    • 4.2.3. Asia Pacific
      • 4.2.3.1. Regional Insights
    • 4.2.4. Latin America
      • 4.2.4.1. Regional Insights
    • 4.2.5. Middle East & Africa
      • 4.2.5.1. Regional Insights
  • 4.3. Global Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Region
• 5. North America Next Generation Cancer Diagnostics Market Analysis and Forecast, 2020-2034
  • 5.1. Key Findings
  • 5.2. North America Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 5.3. North America Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Product Type
  • 5.4. North America Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 5.5. North America Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Application
  • 5.6. North America Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  • 5.7. North America Next Generation Cancer Diagnostics Market Attractiveness Analysis, By End-user
  • 5.8. North America Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 5.9. North America Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Country
    • 5.9.1. The US
    • 5.9.2. Canada
• 6. Europe Next Generation Cancer Diagnostics Market Analysis and Forecast, 2020-2034
  • 6.1. Key Findings
  • 6.2. Europe Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 6.3. Europe Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Product Type
  • 6.4. Europe Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 6.5. Europe Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Application
  • 6.6. Europe Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  • 6.7. Europe Next Generation Cancer Diagnostics Market Attractiveness Analysis, By End-user
  • 6.8. Europe Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 6.9. Europe Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Country
    • 6.9.1. Germany
    • 6.9.2. The UK
    • 6.9.3. France
    • 6.9.4. Spain
    • 6.9.5. Italy
    • 6.9.6. Russia
    • 6.9.7. Netherland
    • 6.9.8. Rest of Europe
• 7. Asia Pacific Next Generation Cancer Diagnostics Market Analysis and Forecast, 2020-2034
  • 7.1. Key Findings
  • 7.2. Asia Pacific Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 7.3. Asia Pacific Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Product Type
  • 7.4. Asia Pacific Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 7.5. Asia Pacific Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Application
  • 7.6. Asia Pacific Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  • 7.7. Asia Pacific Next Generation Cancer Diagnostics Market Attractiveness Analysis, By End-user
  • 7.8. Asia Pacific Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 7.9. Asia Pacific Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Country
    • 7.9.1. China
    • 7.9.2. Japan
    • 7.9.3. South Korea
    • 7.9.4. India
    • 7.9.5. Australia
    • 7.9.6. New Zealand
    • 7.9.7. Singapore
    • 7.9.8. Thailand
    • 7.9.9. Vietnam
    • 7.9.10. Rest of Asia Pacific
• 8. Latin America Next Generation Cancer Diagnostics Market Analysis and Forecast, 2020-2034
  • 8.1. Key Findings
  • 8.2. Latin America Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 8.3. Latin America Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Product Type
  • 8.4. Latin America Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 8.5. Latin America Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Application
  • 8.6. Latin America Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  • 8.7. Latin America Next Generation Cancer Diagnostics Market Attractiveness Analysis, By End-user
  • 8.8. Latin America Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 8.9. Latin America Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Country
    • 8.9.1. Brazil
    • 8.9.2. Mexico
    • 8.9.3. Rest of Latin America
• 9. Middle East & Africa Next Generation Cancer Diagnostics Market Analysis and Forecast, 2020-2034
  • 9.1. Key Findings
  • 9.2. Middle East & Africa Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 9.3. Middle East & Africa Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Product Type
  • 9.4. Middle East & Africa Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  • 9.5. Middle East & Africa Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Application
  • 9.6. Middle East & Africa Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
  • 9.7. Middle East & Africa Next Generation Cancer Diagnostics Market Attractiveness Analysis, By End-user
  • 9.8. Middle East & Africa Next Generation Cancer Diagnostics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 9.9. Middle East & Africa Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Country
    • 9.9.1. South Africa
    • 9.9.2. Saudi Arabia
    • 9.9.3. UAE
    • 9.9.4. Rest of Middle East & Africa
• 10. Competitive Landscape & Company Profiles
  • 10.1. Market Competition Scenario Analysis, By Company
    • 10.1.1. Key Takeaways
  • 10.2. Overview of Major Market Players
  • 10.3. Competitor Landscape
  • 10.4. Strategic Mapping
  • 10.5. Company Life Cycle Analysis
  • 10.6. Company Market Share Analysis
  • 10.7. Company Profiles
    • 10.7.1. Thermo Fisher Scientific Inc
      • 10.7.1.1. Company Details
      • 10.7.1.2. Business Overview
      • 10.7.1.3. Product Portfolio
      • 10.7.1.4. Financial Insights
      • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.1.6. SWOT Analysis
      • 10.7.1.7. Geographic Footprint
    • 10.7.2. QIAGEN
      • 10.7.2.1. Company Details
      • 10.7.2.2. Business Overview
      • 10.7.2.3. Product Portfolio
      • 10.7.2.4. Financial Insights
      • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.2.6. SWOT Analysis
      • 10.7.2.7. Geographic Footprint
    • 10.7.3. Novartis AG
      • 10.7.3.1. Company Details
      • 10.7.3.2. Business Overview
      • 10.7.3.3. Product Portfolio
      • 10.7.3.4. Financial Insights
      • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.3.6. SWOT Analysis
      • 10.7.3.7. Geographic Footprint
    • 10.7.4. Illumina, Inc
      • 10.7.4.1. Company Details
      • 10.7.4.2. Business Overview
      • 10.7.4.3. Product Portfolio
      • 10.7.4.4. Financial Insights
      • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.4.6. SWOT Analysis
      • 10.7.4.7. Geographic Footprint
    • 10.7.5. GE HealthCare
      • 10.7.5.1. Company Details
      • 10.7.5.2. Business Overview
      • 10.7.5.3. Product Portfolio
      • 10.7.5.4. Financial Insights
      • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.5.6. SWOT Analysis
      • 10.7.5.7. Geographic Footprint
    • 10.7.6. F. Hoffmann-La Roche Ltd
      • 10.7.6.1. Company Details
      • 10.7.6.2. Business Overview
      • 10.7.6.3. Product Portfolio
      • 10.7.6.4. Financial Insights
      • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.6.6. SWOT Analysis
      • 10.7.6.7. Geographic Footprint
    • 10.7.7. Agilent Technologies, Inc
      • 10.7.7.1. Company Details
      • 10.7.7.2. Business Overview
      • 10.7.7.3. Product Portfolio
      • 10.7.7.4. Financial Insights
      • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.7.6. SWOT Analysis
      • 10.7.7.7. Geographic Footprint
    • 10.7.8. Abbott
      • 10.7.8.1. Company Details
      • 10.7.8.2. Business Overview
      • 10.7.8.3. Product Portfolio
      • 10.7.8.4. Financial Insights
      • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.8.6. SWOT Analysis
      • 10.7.8.7. Geographic Footprint
• 11. Methodology and Data Source
  • 11.1. Methodology/Research Approach
  • 11.2. Market Size Estimation
  • 11.3. Market Breakdown and Data Triangulation
  • 11.4. Data Source
  • 11.5. Secondary Sources
  • 11.6. Primary Sources
  • 11.7. Appendix
  • 11.8. Disclaimer

List of Tables

• Table 1. Global Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 2. Global Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 3. Global Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 4. Global Next Generation Cancer Diagnostics Market Value (US$ Mn), By Region, 2020-2034
• Table 5. North America Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 6. North America Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 7. North America Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 8. North America Next Generation Cancer Diagnostics Market Value (US$ Mn), By Country, 2020-2034
• Table 9. The US Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 10. The US Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 11. The US Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 12. Canada Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 13. Canada Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 14. Canada Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 15. Europe Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 16. Europe Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 17. Europe Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 18. Europe Next Generation Cancer Diagnostics Market Value (US$ Mn), By Country, 2020-2034
• Table 19. Germany Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 20. Germany Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 21. Germany Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 22. The UK Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 23. The UK Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 24. The UK Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 25. France Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 26. France Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 27. France Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 28. Spain Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 29. Spain Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 30. Spain Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 31. Italy Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 32. Italy Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 33. Italy Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 34. Russia Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 35. Russia Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 36. Russia Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 37. Netherland Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 38. Netherland Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 39. Netherland Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 40. Rest of Europe Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 41. Rest of Europe Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 42. Rest of Europe Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 43. Asia Pacific Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 44. Asia Pacific Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 45. Asia Pacific Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 46. Asia Pacific Next Generation Cancer Diagnostics Market Value (US$ Mn), By Country, 2020-2034
• Table 47. China Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 48. China Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 49. China Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 50. India Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 51. India Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 52. India Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 53. Japan Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 54. Japan Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 55. Japan Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 56. South Korea Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 57. South Korea Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 58. South Korea Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 59. Australia Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 60. Australia Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 61. Australia Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 62. New Zealand Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 63. New Zealand Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 64. New Zealand Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 65. Singapore Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 66. Singapore Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 67. Singapore Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 68. Thailand Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 69. Thailand Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 70. Thailand Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 71. Vietnam Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 72. Vietnam Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 73. Vietnam Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 74. Rest of Asia Pacific Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 75. Rest of Asia Pacific Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 76. Rest of Asia Pacific Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 77. Latin America Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 78. Latin America Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 79. Latin America Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 80. Latin America Next Generation Cancer Diagnostics Market Value (US$ Mn), By Country, 2020-2034
• Table 81. Brazil Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 82. Brazil Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 83. Brazil Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 84. Mexico Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 85. Mexico Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 86. Mexico Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 87. Rest of Latin America Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 88. Rest of Latin America Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 89. Rest of Latin America Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 90. Middle East & Africa Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 91. Middle East & Africa Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 92. Middle East & Africa Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 93. Middle East & Africa Next Generation Cancer Diagnostics Market Value (US$ Mn), By Country, 2020-2034
• Table 94. South Africa Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 95. South Africa Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 96. South Africa Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 97. Saudi Arabia Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 98. Saudi Arabia Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 99. Saudi Arabia Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 100. UAE Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 101. UAE Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 102. UAE Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034
• Table 103. Rest of Middle East & Africa Next Generation Cancer Diagnostics Market Value (US$ Mn), By Product Type, 2020-2034
• Table 104. Rest of Middle East & Africa Next Generation Cancer Diagnostics Market Value (US$ Mn), By Application, 2020-2034
• Table 105. Rest of Middle East & Africa Next Generation Cancer Diagnostics Market Value (US$ Mn), By End-user, 2020-2034

List of Figures

• Figure 1. Global Next Generation Cancer Diagnostics Market Snapshot: Market Value (US$ Mn), 2020-2034
• Figure 2. Opportunity Map
• Figure 3. Opportunity Orbit
• Figure 4. Regional Market Share and BPS Analysis in Next Generation Cancer Diagnostics Market
• Figure 5. Global Next Generation Cancer Diagnostics Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 6. Global Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Product Type
• Figure 7. Global Next Generation Cancer Diagnostics Market Analysis, By Application, 2020, 2024 and 2034
• Figure 8. Global Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Application
• Figure 9. Global Next Generation Cancer Diagnostics Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 10. Global Next Generation Cancer Diagnostics Market Attractiveness Analysis, By End-user
• Figure 11. Global Next Generation Cancer Diagnostics Market Analysis, By Region, 2020, 2024 and 2034
• Figure 12. Global Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Region
• Figure 13. North America Next Generation Cancer Diagnostics Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 14. North America Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Product Type
• Figure 15. North America Next Generation Cancer Diagnostics Market (US$ Mn), by Next Generation Sequencing, 2020-2034
• Figure 16. North America Next Generation Cancer Diagnostics Market (US$ Mn), by Liquid Biopsy, 2020-2034
• Figure 17. North America Next Generation Cancer Diagnostics Market (US$ Mn), by Genetic Testing, 2020-2034
• Figure 18. North America Next Generation Cancer Diagnostics Market (US$ Mn), by Immunoassays, 2020-2034
• Figure 19. North America Next Generation Cancer Diagnostics Market (US$ Mn), by Radiomics, 2020-2034
• Figure 20. North America Next Generation Cancer Diagnostics Market Analysis, By Application, 2020, 2024 and 2034
• Figure 21. North America Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Application
• Figure 22. North America Next Generation Cancer Diagnostics Market (US$ Mn), by Breast Cancer, 2020-2034
• Figure 23. North America Next Generation Cancer Diagnostics Market (US$ Mn), by Colorectal Cancer, 2020-2034
• Figure 24. North America Next Generation Cancer Diagnostics Market (US$ Mn), by Lung Cancer, 2020-2034
• Figure 25. North America Next Generation Cancer Diagnostics Market (US$ Mn), by Prostate Cancer, 2020-2034
• Figure 26. North America Next Generation Cancer Diagnostics Market (US$ Mn), by Leukemia, 2020-2034
• Figure 27. North America Next Generation Cancer Diagnostics Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 28. North America Next Generation Cancer Diagnostics Market Attractiveness Analysis, By End-user
• Figure 29. North America Next Generation Cancer Diagnostics Market (US$ Mn), by Hospitals, 2020-2034
• Figure 30. North America Next Generation Cancer Diagnostics Market (US$ Mn), by Research Institutions, 2020-2034
• Figure 31. North America Next Generation Cancer Diagnostics Market (US$ Mn), by Laboratories, 2020-2034
• Figure 32. North America Next Generation Cancer Diagnostics Market (US$ Mn), by Diagnostic Centers, 2020-2034
• Figure 33. North America Next Generation Cancer Diagnostics Market Analysis, By Country, 2020, 2024 and 2034
• Figure 34. North America Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Country
• Figure 35. Europe Next Generation Cancer Diagnostics Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 36. Europe Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Product Type
• Figure 37. Europe Next Generation Cancer Diagnostics Market (US$ Mn), by Next Generation Sequencing, 2020-2034
• Figure 38. Europe Next Generation Cancer Diagnostics Market (US$ Mn), by Liquid Biopsy, 2020-2034
• Figure 39. Europe Next Generation Cancer Diagnostics Market (US$ Mn), by Genetic Testing, 2020-2034
• Figure 40. Europe Next Generation Cancer Diagnostics Market (US$ Mn), by Immunoassays, 2020-2034
• Figure 41. Europe Next Generation Cancer Diagnostics Market (US$ Mn), by Radiomics, 2020-2034
• Figure 42. Europe Next Generation Cancer Diagnostics Market Analysis, By Application, 2020, 2024 and 2034
• Figure 43. Europe Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Application
• Figure 44. Europe Next Generation Cancer Diagnostics Market (US$ Mn), by Breast Cancer, 2020-2034
• Figure 45. Europe Next Generation Cancer Diagnostics Market (US$ Mn), by Colorectal Cancer, 2020-2034
• Figure 46. Europe Next Generation Cancer Diagnostics Market (US$ Mn), by Lung Cancer, 2020-2034
• Figure 47. Europe Next Generation Cancer Diagnostics Market (US$ Mn), by Prostate Cancer, 2020-2034
• Figure 48. Europe Next Generation Cancer Diagnostics Market (US$ Mn), by Leukemia, 2020-2034
• Figure 49. Europe Next Generation Cancer Diagnostics Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 50. Europe Next Generation Cancer Diagnostics Market Attractiveness Analysis, By End-user
• Figure 51. Europe Next Generation Cancer Diagnostics Market (US$ Mn), by Hospitals, 2020-2034
• Figure 52. Europe Next Generation Cancer Diagnostics Market (US$ Mn), by Research Institutions, 2020-2034
• Figure 53. Europe Next Generation Cancer Diagnostics Market (US$ Mn), by Laboratories, 2020-2034
• Figure 54. Europe Next Generation Cancer Diagnostics Market (US$ Mn), by Diagnostic Centers, 2020-2034
• Figure 55. Europe Next Generation Cancer Diagnostics Market Analysis, By Country, 2020, 2024 and 2034
• Figure 56. Europe Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Country
• Figure 57. Asia Pacific Next Generation Cancer Diagnostics Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 58. Asia Pacific Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Product Type
• Figure 59. Asia Pacific Next Generation Cancer Diagnostics Market (US$ Mn), by Next Generation Sequencing, 2020-2034
• Figure 60. Asia Pacific Next Generation Cancer Diagnostics Market (US$ Mn), by Liquid Biopsy, 2020-2034
• Figure 61. Asia Pacific Next Generation Cancer Diagnostics Market (US$ Mn), by Genetic Testing, 2020-2034
• Figure 62. Asia Pacific Next Generation Cancer Diagnostics Market (US$ Mn), by Immunoassays, 2020-2034
• Figure 63. Asia Pacific Next Generation Cancer Diagnostics Market (US$ Mn), by Radiomics, 2020-2034
• Figure 64. Asia Pacific Next Generation Cancer Diagnostics Market Analysis, By Application, 2020, 2024 and 2034
• Figure 65. Asia Pacific Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Application
• Figure 66. Asia Pacific Next Generation Cancer Diagnostics Market (US$ Mn), by Breast Cancer, 2020-2034
• Figure 67. Asia Pacific Next Generation Cancer Diagnostics Market (US$ Mn), by Colorectal Cancer, 2020-2034
• Figure 68. Asia Pacific Next Generation Cancer Diagnostics Market (US$ Mn), by Lung Cancer, 2020-2034
• Figure 69. Asia Pacific Next Generation Cancer Diagnostics Market (US$ Mn), by Prostate Cancer, 2020-2034
• Figure 70. Asia Pacific Next Generation Cancer Diagnostics Market (US$ Mn), by Leukemia, 2020-2034
• Figure 71. Asia Pacific Next Generation Cancer Diagnostics Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 72. Asia Pacific Next Generation Cancer Diagnostics Market Attractiveness Analysis, By End-user
• Figure 73. Asia Pacific Next Generation Cancer Diagnostics Market (US$ Mn), by Hospitals, 2020-2034
• Figure 74. Asia Pacific Next Generation Cancer Diagnostics Market (US$ Mn), by Research Institutions, 2020-2034
• Figure 75. Asia Pacific Next Generation Cancer Diagnostics Market (US$ Mn), by Laboratories, 2020-2034
• Figure 76. Asia Pacific Next Generation Cancer Diagnostics Market (US$ Mn), by Diagnostic Centers, 2020-2034
• Figure 77. Asia Pacific Next Generation Cancer Diagnostics Market Analysis, By Country, 2020, 2024 and 2034
• Figure 78. Asia Pacific Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Country
• Figure 79. Latin America Next Generation Cancer Diagnostics Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 80. Latin America Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Product Type
• Figure 81. Latin America Next Generation Cancer Diagnostics Market (US$ Mn), by Next Generation Sequencing, 2020-2034
• Figure 82. Latin America Next Generation Cancer Diagnostics Market (US$ Mn), by Liquid Biopsy, 2020-2034
• Figure 83. Latin America Next Generation Cancer Diagnostics Market (US$ Mn), by Genetic Testing, 2020-2034
• Figure 84. Latin America Next Generation Cancer Diagnostics Market (US$ Mn), by Immunoassays, 2020-2034
• Figure 85. Latin America Next Generation Cancer Diagnostics Market (US$ Mn), by Radiomics, 2020-2034
• LLatin America Next Generation Cancer Diagnostics Market Analysis, By Application, 2020, 2024 and 2034
• Figure 86. Latin America Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Application
• Figure 87. Latin America Next Generation Cancer Diagnostics Market (US$ Mn), by Breast Cancer, 2020-2034
• Figure 88. Latin America Next Generation Cancer Diagnostics Market (US$ Mn), by Colorectal Cancer, 2020-2034
• Figure 89. Latin America Next Generation Cancer Diagnostics Market (US$ Mn), by Lung Cancer, 2020-2034
• Figure 90. Latin America Next Generation Cancer Diagnostics Market (US$ Mn), by Prostate Cancer, 2020-2034
• Figure 91. Latin America Next Generation Cancer Diagnostics Market (US$ Mn), by Leukemia, 2020-2034
• Figure 92. Latin America Next Generation Cancer Diagnostics Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 93. Latin America Next Generation Cancer Diagnostics Market Attractiveness Analysis, By End-user
• Figure 94. Latin America Next Generation Cancer Diagnostics Market (US$ Mn), by Hospitals, 2020-2034
• Figure 95. Latin America Next Generation Cancer Diagnostics Market (US$ Mn), by Research Institutions, 2020-2034
• Figure 96. Latin America Next Generation Cancer Diagnostics Market (US$ Mn), by Laboratories, 2020-2034
• Figure 97. Latin America Next Generation Cancer Diagnostics Market (US$ Mn), by Diagnostic Centers, 2020-2034
• LaLatin America Next Generation Cancer Diagnostics Market Analysis, By Country, 2020, 2024 and 2034
• Figure 98. Latin America Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Country
• Figure 99. Middle East & Africa Next Generation Cancer Diagnostics Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 100. Middle East & Africa Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Product Type
• Figure 101. Middle East & Africa Next Generation Cancer Diagnostics Market (US$ Mn), by Next Generation Sequencing, 2020-2034
• Figure 102. Middle East & Africa Next Generation Cancer Diagnostics Market (US$ Mn), by Liquid Biopsy, 2020-2034
• Figure 103. Middle East & Africa Next Generation Cancer Diagnostics Market (US$ Mn), by Genetic Testing, 2020-2034
• Figure 104. Middle East & Africa Next Generation Cancer Diagnostics Market (US$ Mn), by Immunoassays, 2020-2034
• Figure 105. Middle East & Africa Next Generation Cancer Diagnostics Market (US$ Mn), by Radiomics, 2020-2034
• Figure 106. Middle East & Africa Next Generation Cancer Diagnostics Market Analysis, By Application, 2020, 2024 and 2034
• Figure 107. Middle East & Africa Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Application
• Figure 108. Middle East & Africa Next Generation Cancer Diagnostics Market (US$ Mn), by Breast Cancer, 2020-2034
• Figure 109. Middle East & Africa Next Generation Cancer Diagnostics Market (US$ Mn), by Colorectal Cancer, 2020-2034
• Figure 110. Middle East & Africa Next Generation Cancer Diagnostics Market (US$ Mn), by Lung Cancer, 2020-2034
• Figure 111. Middle East & Africa Next Generation Cancer Diagnostics Market (US$ Mn), by Prostate Cancer, 2020-2034
• Figure 112. Middle East & Africa Next Generation Cancer Diagnostics Market (US$ Mn), by Leukemia, 2020-2034
• Figure 113. Middle East & Africa Next Generation Cancer Diagnostics Market Analysis, By End-user, 2020, 2024 and 2034
• Figure 114. Middle East & Africa Next Generation Cancer Diagnostics Market Attractiveness Analysis, By End-user
• Figure 115. Middle East & Africa Next Generation Cancer Diagnostics Market (US$ Mn), by Hospitals, 2020-2034
• Figure 116. Middle East & Africa Next Generation Cancer Diagnostics Market (US$ Mn), by Research Institutions, 2020-2034
• Figure 117. Middle East & Africa Next Generation Cancer Diagnostics Market (US$ Mn), by Laboratories, 2020-2034
• Figure 118. Middle East & Africa Next Generation Cancer Diagnostics Market (US$ Mn), by Diagnostic Centers, 2020-2034
• Figure 119. Middle East & Africa Next Generation Cancer Diagnostics Market Analysis, By Country, 2020, 2024 and 2034
• Figure 120. Middle East & Africa Next Generation Cancer Diagnostics Market Attractiveness Analysis, By Country